Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1992 1
1994 1
1999 1
2000 2
2001 1
2002 1
2003 2
2004 3
2005 5
2006 3
2007 3
2008 1
2009 4
2010 8
2011 1
2012 3
2013 3
2014 3
2015 1
2016 3
2017 5
2018 9
2019 9
2020 7
2021 10
2022 8
2023 15
2024 9
2025 26
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
CGMap: Characterizing continuous glucose monitor data in thousands of non-diabetic individuals.
Keshet A, Shilo S, Godneva A, Talmor-Barkan Y, Aviv Y, Segal E, Rossman H. Keshet A, et al. Cell Metab. 2023 May 2;35(5):758-769.e3. doi: 10.1016/j.cmet.2023.04.002. Epub 2023 Apr 19. Cell Metab. 2023. PMID: 37080199 Free article.
Despite its rising prevalence, diabetes diagnosis still relies on measures from blood tests. Technological advances in continuous glucose monitoring (CGM) devices introduce a potential tool to expand our understanding of glucose control and variability …
Despite its rising prevalence, diabetes diagnosis still relies on measures from blood tests. Technological advances in continuous
Use of Continuous Glucose Monitoring in Non-diabetic Individuals for Cardiovascular Prevention: A Systematic Review of Its Impact on Guiding Lifestyle Interventions.
Ahmed N, Elzein Ali MF, Hamed Mohamed MN, Mohammed Saad Aldeen RSA, Ibrahim Omer RI, Adam Omer TM, ElTahir Hamza RA, Musa Rabih MR. Ahmed N, et al. Cureus. 2025 Oct 13;17(10):e94460. doi: 10.7759/cureus.94460. eCollection 2025 Oct. Cureus. 2025. PMID: 41246623 Free PMC article. Review.
Cardiovascular disease (CVD) is a leading global cause of mortality, with prevention through lifestyle modification being paramount. Continuous glucose monitoring (CGM), which provides real-time, dynamic glycemic data, is increasingly being explored in non
Cardiovascular disease (CVD) is a leading global cause of mortality, with prevention through lifestyle modification being paramount. Cont
Non-Invasive Continuous Glucose Monitoring in Patients Without Diabetes: Use in Cardiovascular Prevention-A Systematic Review.
Wilczek F, van der Stouwe JG, Petrasch G, Niederseer D. Wilczek F, et al. Sensors (Basel). 2025 Jan 1;25(1):187. doi: 10.3390/s25010187. Sensors (Basel). 2025. PMID: 39796978 Free PMC article.
Continuous glucose monitoring (CGM) might provide immediate feedback regarding lifestyle choices such as diet and physical activity (PA). The impact of dietary habits and physical activity can be demonstrated in real time by providing continuous data o
Continuous glucose monitoring (CGM) might provide immediate feedback regarding lifestyle choices such as diet and physi
Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023.
Worth C, Hoskyns L, Salomon-Estebanez M, Nutter PW, Harper S, Derks TGJ, Beardsall K, Banerjee I. Worth C, et al. Front Endocrinol (Lausanne). 2023 Jan 23;14:1116864. doi: 10.3389/fendo.2023.1116864. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36755920 Free PMC article. Review.
These tasks are increasingly served by Continuous Glucose Monitoring (CGM) devices that measure subcutaneous glucose at near-continuous frequency. ...In this state of the art review, we critically analyse the updated evidence for use of CGM in …
These tasks are increasingly served by Continuous Glucose Monitoring (CGM) devices that measure subcutaneous glucose
Continuous interstitial glucose monitoring in diabetic and non-diabetic critically ill patients is simple and accurate: comparison with venous, arterial and capillary glucose measurements.
Chiumello D, Passeri M, Coppola S, Chiodaroli E, Carnier S, Montante M, Pozzi T, Goggi I, Bifari F, Mortola U, Centofanti L, Folli F. Chiumello D, et al. Acta Diabetol. 2025 Aug;62(8):1173-1181. doi: 10.1007/s00592-025-02531-1. Epub 2025 Jun 7. Acta Diabetol. 2025. PMID: 40481975 Free PMC article.
INTRODUCTION: To reduce mortality, thigh glycemic control is recommended in critically ill patients due to their extreme glycemic variability. Continuous glucose monitoring (CGM) devices allows frequent determination of blood glucose levels; however, c …
INTRODUCTION: To reduce mortality, thigh glycemic control is recommended in critically ill patients due to their extreme glycemic variabilit …
Investigating sensor location on the effectiveness of continuous glucose monitoring during exercise in a non-diabetic population.
Coates AM, Cohen JN, Burr JF. Coates AM, et al. Eur J Sport Sci. 2023 Oct;23(10):2109-2117. doi: 10.1080/17461391.2023.2174452. Epub 2023 Feb 23. Eur J Sport Sci. 2023. PMID: 36715137 Free article.
The purpose of this investigation was to evaluate whether continuous glucose monitoring (CGM) sensors worn on the active muscle may provide enhanced insight into glucose control in non-diabetic participants during cycling exercise compare …
The purpose of this investigation was to evaluate whether continuous glucose monitoring (CGM) sensors worn on the activ …
Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis.
Liao X, Li Y, Tang S, Xiao Y, Yu X, Huang R, Zhong T. Liao X, et al. Eur J Med Res. 2026 Jan 26. doi: 10.1186/s40001-026-03920-0. Online ahead of print. Eur J Med Res. 2026. PMID: 41588451 Free article.
BACKGROUND: Continuous glucose monitoring (CGM) has traditionally been used in diabetes management, but its application is expanding to non-diabetic populations for health promotion and metabolic optimization. ...OBJECTIVES: The aim of this stud …
BACKGROUND: Continuous glucose monitoring (CGM) has traditionally been used in diabetes management, but its application …
Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis.
Sobngwi E, Ashuntantang G, Ndounia E, Dehayem M, Azabji-Kenfack M, Kaze F, Balti E, Mbanya JC. Sobngwi E, et al. Diabetes Res Clin Pract. 2010 Oct;90(1):22-5. doi: 10.1016/j.diabres.2010.06.001. Epub 2010 Aug 11. Diabetes Res Clin Pract. 2010. PMID: 20705354 Clinical Trial.
Haemodialysis improves uraemia-induced insulin sensitivity and is therefore likely to induce significant changes in circulating glucose concentrations in end-stage renal disease (ESRD). We aimed to assess clinically relevant circulating glucose changes in patients u …
Haemodialysis improves uraemia-induced insulin sensitivity and is therefore likely to induce significant changes in circulating glucose
Optimising obesity management: integrating continuous glucose monitoring with GLP-1 receptor agonists.
Gupta P, Pozzilli P. Gupta P, et al. Diabetes Res Clin Pract. 2025 Oct;228:112434. doi: 10.1016/j.diabres.2025.112434. Epub 2025 Aug 21. Diabetes Res Clin Pract. 2025. PMID: 40849048 Review.
Obesity management is evolving with the integration of digital and pharmacological innovations. Continuous Glucose Monitoring (CGM) offers dynamic insights into glucose variability, while glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as s …
Obesity management is evolving with the integration of digital and pharmacological innovations. Continuous Glucose Monitori
146 results